Race against time: can surgery within hours save brain bleed patients?
NCT ID NCT07260916
First seen Jun 27, 2026 · Last updated Jun 30, 2026 · Updated 2 times
Summary
This trial tests whether removing a brain bleed with a minimally invasive scope within hours of symptoms improves recovery. 300 adults with a specific type of brain bleed will be randomly assigned to either get the surgery plus standard care, or standard care alone. The study will track disability and quality of life for one year.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- minimally invasive endoscopic surgery (SCUBA approach)
- What this could lead to
- If successful, this could establish a new standard for ultra-early surgical removal of brain bleeds, potentially improving survival and quality of life for stroke patients.
- What could go wrong
- This is an early-stage trial (Phase NA) with a small sample size (300). The surgery is invasive and carries risks like infection or rebleeding. Results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BASAL GANGLIA INTRACEREBRAL HEMORRHAGE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mount Sinai Health System
RECRUITINGNew York, New York, 10029, United States
-
Robert Wood Johnson University Hospital
RECRUITINGNew Brunswick, New Jersey, 08901, United States